AMGN compared with PLUR: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

PLURPluri Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

PLURPluri Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34· pre 479.89· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

PLURPluri Inc.

1.24· pre 1.23· delayed

Pre-marketNov 5 '26delayed

Mkt cap$15.2MRevenue$335,000Q4 FY26Revenue$1MFY26

Compare

Pre-marketNov 5 '26delayed

AMGNAmgen Inc

PLURPluri Inc.

478.34pre 479.89delayed

Price

1.24pre 1.23delayed

$258.8B

Mkt cap

$15.2M

Q3 FY26$10.4B

Revenue

$335,000Q4 FY26

FY25$36.8B

Revenue

$1MFY26

AMGN478.34vsPLUR1.24Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PLUR: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

AMGN, solidPLUR, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only PLUR 3

NCELNewcelXcustomer

—Bar-Ilan University Research and Developmentunlistedcustomer

—Novadipunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR